Future Fields

Future Fields is a biotechnology company based in Edmonton, Alberta, Canada, founded in 2018. The company specializes in sustainable protein production using genetically engineered fruit flies, specifically *Drosophila melanogaster*. Future Fields has developed the EntoEngine™ platform, which is the first synthetic biology system to utilize fruit flies for commercial recombinant protein manufacturing. This innovative approach significantly reduces production costs and minimizes environmental impact.

The company produces serum-free growth factors and customized cell growth media for applications in cellular agriculture and biopharmaceuticals. Their offerings support various sectors, including pharmaceutical manufacturing, cultivated meat production, food technology, and medical research. Future Fields has collaborated with companies like Jenthera Therapeutics to manufacture cancer-fighting proteins. With a team of around 30 employees, the company has raised $11.2 million in funding and generated $6.3 million in revenue. Future Fields is committed to sustainability, contributing to environmental initiatives and achieving high certification levels for its lab practices.